advanced search

Welcome: Guest

log in

0 items in basket Total: £0
$0 / €0

View Basket

United States Neurology Devices Investment Opportunities

Analysis and Forecasts to 2015

Publication Date April 2009
Publisher Global Markets Direct
Product Type Report
Pages 201
ISBN Number not applicable
Product Code GMD07492
Buy this product or for assistance call +44 20 7060 7474
PDF £1,570$2,503 | €1,795
FAX Order above formats by FAX

Summary

This report is an essential source for in-depth information and data relating to United States neurology devices market. It also offers detailed and comprehensive coverage of market revenue, volume, distribution and company share information; and latest news, financial deals and pipeline products information of each of the key sub-segments of the neurology devices in United States

Scope

  • The report provides neurology devices information broken down into detailed categories and segments in United States.
  • Total revenues, products sold, end users, and average pricing.
  • Market shares of all the key competitors.
  • Key pipeline products that are set to shape the market, broken down by sector.
  • Information on the top medical equipment companies in the sector in the country covering business description, strategic analysis, and financial information.
  • Healthcare structure, regulatory environment, approval process, pricing trends and reimbursement.
  • Product and brand updates, strategy changes, R&D projects, corporate expansions and contractions and regulatory changes.
  • Key mergers and acquisitions, partnerships, private equity investments and IPOs.
  • Customer, hospitals and physicians data.

Reasons to buy

  • Gain a strong understanding of the neurology devices market in United States.
  • Evaluate and compare the attractiveness of the market in the country.
  • Identify growth segments and opportunities in each industry sector within the country.
  • Evaluate the pipeline of key products that will change the sector, and identify threats and opportunities before the products are launched in the country.
  • Analyze the competitiveness of the market in the country and identify hotspots.
  • Develop strategies based on the latest product, brand, expansion and research and development news in the country.
  • Do deals with an understanding of how competitors are financed, and the mergers and partnerships that have shaped the market in the country.
  • Identify and analyze the strengths and weaknesses of the industry incumbents in the country.

Content

  • 1 List of Tables
  • 1.2 List of Figures
  • 2 Introduction
    • 2.1 What Is This Report About?
  • 3 Definitions of Markets Covered in This Report
    • 3.1 Neurology Devices
    • 3.2 CSF Management
    • 3.3 Interventional Neurology
    • 3.4 Neurostimulation Devices
    • 3.5 Neurosurgical Products
    • 3.6 Radiosurgery
  • 4 Healthcare Sector Review
    • 4.1 Healthcare Expenditure
    • 4.2 Healthcare Infrastructure
    • 4.3 United States Healthcare Trade Statistics
  • 5 Regulation System
    • 5.1 Regulation System
    • 5.2 Medical Equipment Approval Process
  • 6 Pricing and Reimbursement
    • 6.1 Government Policies
    • 6.2 Private Insurance
    • 6.3 Diagnosis Related Groups (DRG)
  • 7 Distribution Structure
    • 7.1 Distribution Structure
  • 8 Neurology Devices In United States
    • 8.1 Neurology Devices Cross Country Comparison, Revenue ($ mn), 2000-2015
    • 8.2 Neurology Devices, United States, Overall Revenue ($ mn), 2000-2015
    • 8.3 Neurology Devices, United States, Category Volume (Units), 2000-2015
    • 8.4 Neurology Devices, United States, Company Share (2006-2007)
  • 9 CSF Management In United States
    • 9.1 CSF Management Overall Revenue (2000-2015)
    • 9.2 CSF Management Overall Volume (2000-2015)
    • 9.3 CSF Management Average Price (2000-2015)
    • 9.4 CSF Management Distribution Share (2007-2008)
    • 9.5 CSF Management, United States, Company Share (2006-2007)
  • 10 Interventional Neurology In United States
    • 10.1 Interventional Neurology Overall Revenue (2000-2015)
    • 10.2 Interventional Neurology Overall Volume (2000-2015)
    • 10.3 Interventional Neurology Average Price (2000-2015)
    • 10.4 Interventional Neurology Distribution Share (2007-2008)
    • 10.5 Interventional Neurology, United States, Company Share (2006-2007)
  • 11 Neurostimulation Devices In United States
    • 11.1 Neurostimulation Devices Overall Revenue (2000-2015)
    • 11.2 Neurostimulation Devices Overall Volume (2000-2015)
    • 11.3 Neurostimulation Devices Average Price (2000-2015)
    • 11.4 Neurostimulation Devices Distribution Share (2007-2008)
    • 11.5 Neurostimulation Devices, United States, Company Share (2006-2007)
  • 12 Neurosurgical Products In United States
    • 12.1 Neurosurgical Products Overall Revenue (2000-2015)
    • 12.2 Neurosurgical Products Overall Volume (2000-2015)
    • 12.3 Neurosurgical Products Average Price (2000-2015)
    • 12.4 Neurosurgical Products Distribution Share (2007-2008)
    • 12.5 Neurosurgical Products, United States, Company Share (2006-2007)
  • 13 Radiosurgery In United States
    • 13.1 Radiosurgery Overall Revenue (2000-2015)
    • 13.2 Radiosurgery Overall Volume (2000-2015)
    • 13.3 Radiosurgery Average Price (2000-2015)
    • 13.4 Radiosurgery Distribution Share (2007-2008)
    • 13.5 Radiosurgery, United States, Company Share (2006-2007)
  • 14 Overview of Key Companies in United States Neurology Devices Market
    • 14.1 Medtronic, Inc
    • 14.2 Boston Scientific Corporation
    • 14.3 Cordis Corporation
    • 14.4 Elekta AB
    • 14.5 Cyberonics, Inc
    • 14.6 KARL STORZ GmbH & Co. KG
    • 14.7 OLYMPUS CORPORATION
    • 14.8 B. Braun Melsungen AG
    • 14.9 Accuray Incorporated
    • 14.10 Integra LifeSciences Holdings Corporation
    • 14.11 ev3 Inc
    • 14.12 St. Jude Medical, Inc
    • 14.13 Cyberkinetics Neurotechnology Systems, Inc
    • 14.14 NeuroPro Technologies, Inc
    • 14.15 Leptos Biomedical, Inc
    • 14.16 Nfocus Neuromedical Inc
    • 14.17 Infinite Biomedical Technologies, LLC
    • 14.18 Northstar Neuroscience, Inc
    • 14.19 NDI Medical
    • 14.20 NeuroPace, Inc
    • 14.21 Neuronetrix, Inc
    • 14.22 VIASYS Healthcare Inc
    • 14.23 Intelect Medical Inc
    • 14.24 Neuralieve, Inc
    • 14.25 Codman & Shurtleff, Inc
    • 14.26 Nevro Corporation
    • 14.27 Wicab, Inc
    • 14.28 MICROTRANSPONDER, INC
    • 14.29 Neostim, Inc
    • 14.30 NeuroMetrix, Inc
    • 14.31 PhotoThera, Inc
    • 14.32 BrainScope
  • 15 Financial Deals Landscape
    • 15.1 Detailed Deal Summary
  • 16 Recent Developments
    • 16.1 Legal and Regulatory
    • 16.2 Government and Public Interest
    • 16.3 Product News
  • 17 Appendix
    • 17.1 Global Markets Direct Research Methodology
    • 17.2 Coverage
    • 17.3 Secondary Research
    • 17.4 Primary Research
    • 17.5 Models
    • 17.6 Forecasts
    • 17.7 Expert Panel Validation
    • 17.8 Currency Conversion
    • 17.9 Contact Us
    • 17.10 Disclaimer
  • 1 List of Tables
    • Table 1: United States Healthcare Expenditure, 2003-2010
    • Table 2: United States Healthcare Expenditure by Age (per person), 2000-2003
    • Table 3: United States Healthcare Expenditure by Sex (per person), 2000-2003
    • Table 4: United States Healthcare Expenditure by Race (per person), 2000-2003
    • Table 5: United States Personal Healthcare Expenditure by Type, 2000-2004
    • Table 6: United States Personal Healthcare Expenditure by Source, 2000-2004
    • Table 7: Total Number of Doctors in the United States, 2003-2010
    • Table 8: Number of Doctors by Specialty in the United States, 2003-2010
    • Table 9: Doctors by Region (Number per 10,000 Civilian Population), 2002-2004
    • Table 10: Doctors by Region (Number per 10,000 Civilian Population), 2002-2004 (Cont.)
    • Table 11: Total Hospitals in the United States, 2000-2004
    • Table 12: Community Hospitals by Number of Beds in the United States, 2000-2004
    • Table 13: Number of Hospital Beds in the United States, 2000-2004
    • Table 14: Number of Hospital Beds by Range in the United States, 2000-2004
    • Table 15: United States Healthcare Trade Statistics, 2001-2006
    • Table 16: Medical Equipment Registration Fee in United States, 2007
    • Table 17: Medical Device Approval Time in United States, 2004
    • Table 18: Neurology Devices Cross Country Comparison, Revenue ($ mn), 2000-2015
    • Table 19: Neurology Devices, United States, Overall Revenue ($ mn), 2000-2015
    • Table 20: Neurology Devices, United States, Overall Revenue ($ mn), 2000-2015
    • Table 21: Neurology Devices, United States, Overall Revenue ($ mn), Historic, 2000-2008
    • Table 22: Neurology Devices, United States, Overall Revenue ($ mn), Forecast, 2008-2015
    • Table 23: Neurology Devices, United States, Category Volume (Units), 2000-2015
    • Table 24: Neurology Devices, United States, Category Volume (Units), Historic, 2000-2008
    • Table 25: Neurology Devices, United States, Category Volume (Units), Forecast, 2008-2015
    • Table 26: Neurology Devices, United States, Company Share by Revenue ($ mn), 2006-2007
    • Table 27: CSF Management, United States, Revenue ($ mn) by Segment , Historic, 2000-2008
    • Table 28: CSF Management, United States, Revenue ($ mn) by Segment , Forecast, 2008-2015
    • Table 29: CSF Management, United States, Volume (Units), Historic, 2000-2008
    • Table 30: CSF Management, United States, Volume (Units), Forecast, 2008-2015
    • Table 31: CSF Management, United States, Average Price ($), Historic, 2000-2008
    • Table 32: CSF Management, United States, Average Price ($), Forecast,, 2008-2015
    • Table 33: CSF Management, United States, Distribution Share by Revenue ($mn), 2007-2008
    • Table 34: CSF Management, United States, Company Share by Revenue ($ mn), 2006-2007
    • Table 35: Interventional Neurology, United States, Revenue ($ mn) by Segment , Historic, 2000-2008
    • Table 36: Interventional Neurology, United States, Revenue ($ mn) by Segment , Forecast, 2008-2015
    • Table 37: Embolic Systems, United States, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008
    • Table 38: Embolic Systems, United States, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015
    • Table 39: Navigational Systems, United States, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008
    • Table 40: Navigational Systems, United States, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015
    • Table 41: Interventional Neurology, United States, Volume (Units), Historic, 2000-2008
    • Table 42: Interventional Neurology, United States, Volume (Units), Forecast, 2008-2015
    • Table 43: Embolic Systems, United States, Volume (Units) by Sub-Segment, Historic, 2000-2008
    • Table 44: Embolic Systems, United States, Volume (Units) by Sub-Segment, Forecast, 2008-2015
    • Table 45: Navigational Systems, United States, Volume (Units) by Sub-Segment, Historic, 2000-2008
    • Table 46: Navigational Systems, United States, Volume (Units) by Sub-Segment, Forecast, 2008-2015
    • Table 47: Interventional Neurology, United States, Average Price ($), Historic, 2000-2008
    • Table 48: Interventional Neurology, United States, Average Price ($), Forecast,, 2008-2015
    • Table 49: Interventional Neurology, United States, Distribution Share by Revenue ($mn), 2007-2008
    • Table 50: Interventional Neurology, United States, Company Share by Revenue ($ mn), 2006-2007
    • Table 51: Neurostimulation Devices, United States, Revenue ($ mn) by Segment , Historic, 2000-2008
    • Table 52: Neurostimulation Devices, United States, Revenue ($ mn) by Segment , Forecast, 2008-2015
    • Table 53: Neurostimulation Devices, United States, Volume (Units), Historic, 2000-2008
    • Table 54: Neurostimulation Devices, United States, Volume (Units), Forecast, 2008-2015
    • Table 55: Neurostimulation Devices, United States, Average Price ($), Historic, 2000-2008
    • Table 56: Neurostimulation Devices, United States, Average Price ($), Forecast,, 2008-2015
    • Table 57: Neurostimulation Devices, United States, Distribution Share by Revenue ($mn), 2007-2008
    • Table 58: Neurostimulation Devices, United States, Company Share by Revenue ($ mn), 2006-2007
    • Table 59: Neurosurgical Products, United States, Revenue ($ mn) by Segment , Historic, 2000-2008
    • Table 60: Neurosurgical Products, United States, Revenue ($ mn) by Segment , Forecast, 2008-2015
    • Table 61: Neurosurgical Products, United States, Volume (Units), Historic, 2000-2008
    • Table 62: Neurosurgical Products, United States, Volume (Units), Forecast, 2008-2015
    • Table 63: Neurosurgical Products, United States, Average Price ($), Historic, 2000-2008
    • Table 64: Neurosurgical Products, United States, Average Price ($), Forecast,, 2008-2015
    • Table 65: Neurosurgical Products, United States, Distribution Share by Revenue ($mn), 2007-2008
    • Table 66: Neurosurgical Products, United States, Company Share by Revenue ($ mn), 2006-2007
    • Table 67: Radiosurgery, United States, Revenue ($ mn) by Segment , Historic, 2000-2008
    • Table 68: Radiosurgery, United States, Revenue ($ mn) by Segment , Forecast, 2008-2015
    • Table 69: Radiosurgery, United States, Volume (Units), Historic, 2000-2008
    • Table 70: Radiosurgery, United States, Volume (Units), Forecast, 2008-2015
    • Table 71: Radiosurgery, United States, Average Price ($), Historic, 2000-2008
    • Table 72: Radiosurgery, United States, Average Price ($), Forecast,, 2008-2015
    • Table 73: Radiosurgery, United States, Distribution Share by Revenue ($mn), 2007-2008
    • Table 74: Radiosurgery, United States, Company Share by Revenue ($ mn), 2006-2007
    • Table 75: Medtronic, Inc. Pipeline Products by Equipment Type
    • Table 76: Medtronic, Inc. Pipeline Products By Development Stage
    • Table 77: Medtronic, Inc. Pipeline Products By Therapy Area
    • Table 78: Medtronic, Inc. Pipeline Products By Clinical Trials
    • Table 79: Medtronic, Inc. Pipeline Products By News Summary
    • Table 80: Boston Scientific Corporation Pipeline Products by Equipment Type
    • Table 81: Boston Scientific Corporation Pipeline Products By Development Stage
    • Table 82: Boston Scientific Corporation Pipeline Products By Therapy Area
    • Table 83: Boston Scientific Corporation Pipeline Products By Clinical Trials
    • Table 84: Boston Scientific Corporation Pipeline Products By News Summary
    • Table 85: Elekta AB Pipeline Products by Equipment Type
    • Table 86: Elekta AB Pipeline Products By Development Stage
    • Table 87: Elekta AB Pipeline Products By Therapy Area
    • Table 88: Elekta AB Pipeline Products By News Summary
    • Table 89: Cyberonics, Inc. Pipeline Products by Equipment Type
    • Table 90: Cyberonics, Inc. Pipeline Products By Development Stage
    • Table 91: Cyberonics, Inc. Pipeline Products By Therapy Area
    • Table 92: ev3 Inc. Pipeline Products by Equipment Type
    • Table 93: ev3 Inc. Pipeline Products By Development Stage
    • Table 94: ev3 Inc. Pipeline Products By Therapy Area
    • Table 95: ev3 Inc. Pipeline Products By Clinical Trials
    • Table 96: ev3 Inc. Pipeline Products By News Summary
    • Table 97: Cyberkinetics Neurotechnology Systems, Inc. Pipeline Products by Equipment Type
    • Table 98: Cyberkinetics Neurotechnology Systems, Inc. Pipeline Products By Development Stage
    • Table 99: Cyberkinetics Neurotechnology Systems, Inc. Pipeline Products By Therapy Area
    • Table 100: Cyberkinetics Neurotechnology Systems, Inc. Pipeline Products By Clinical Trials
    • Table 101: Cyberkinetics Neurotechnology Systems, Inc. Pipeline Products By News Summary
    • Table 102: NeuroPro Technologies, Inc. Pipeline Products by Equipment Type
    • Table 103: NeuroPro Technologies, Inc. Pipeline Products By Development Stage
    • Table 104: NeuroPro Technologies, Inc. Pipeline Products By Therapy Area
    • Table 105: Leptos Biomedical, Inc. Pipeline Products by Equipment Type
    • Table 106: Leptos Biomedical, Inc. Pipeline Products By Development Stage
    • Table 107: Leptos Biomedical, Inc. Pipeline Products By Therapy Area
    • Table 108: Nfocus Neuromedical Inc. Pipeline Products by Equipment Type
    • Table 109: Nfocus Neuromedical Inc. Pipeline Products By Development Stage
    • Table 110: Nfocus Neuromedical Inc. Pipeline Products By Therapy Area
    • Table 111: Nfocus Neuromedical Inc. Pipeline Products By News Summary
    • Table 112: Infinite Biomedical Technologies, LLC Pipeline Products by Equipment Type
    • Table 113: Infinite Biomedical Technologies, LLC Pipeline Products By Development Stage
    • Table 114: Infinite Biomedical Technologies, LLC Pipeline Products By Therapy Area
    • Table 115: Infinite Biomedical Technologies, LLC Pipeline Products By Clinical Trials
    • Table 116: Northstar Neuroscience, Inc. Pipeline Products by Equipment Type
    • Table 117: Northstar Neuroscience, Inc. Pipeline Products By Development Stage
    • Table 118: Northstar Neuroscience, Inc. Pipeline Products By Therapy Area
    • Table 119: Northstar Neuroscience, Inc. Pipeline Products By Clinical Trials
    • Table 120: Northstar Neuroscience, Inc. Pipeline Products By News Summary
    • Table 121: NDI Medical Pipeline Products by Equipment Type
    • Table 122: NDI Medical Pipeline Products By Development Stage
    • Table 123: NDI Medical Pipeline Products By Therapy Area
    • Table 124: NeuroPace, Inc. Pipeline Products by Equipment Type
    • Table 125: NeuroPace, Inc. Pipeline Products By Development Stage
    • Table 126: NeuroPace, Inc. Pipeline Products By Therapy Area
    • Table 127: NeuroPace, Inc. Pipeline Products By Clinical Trials
    • Table 128: Neuronetrix, Inc. Pipeline Products by Equipment Type
    • Table 129: Neuronetrix, Inc. Pipeline Products By Development Stage
    • Table 130: Neuronetrix, Inc. Pipeline Products By Therapy Area
    • Table 131: Neuronetrix, Inc. Pipeline Products By Clinical Trials
    • Table 132: Neuronetrix, Inc. Pipeline Products By News Summary
    • Table 133: Intelect Medical Inc. Pipeline Products by Equipment Type
    • Table 134: Intelect Medical Inc. Pipeline Products By Development Stage
    • Table 135: Intelect Medical Inc. Pipeline Products By Therapy Area
    • Table 136: Neuralieve, Inc. Pipeline Products by Equipment Type
    • Table 137: Neuralieve, Inc. Pipeline Products By Development Stage
    • Table 138: Neuralieve, Inc. Pipeline Products By Therapy Area
    • Table 139: Neuralieve, Inc. Pipeline Products By Clinical Trials
    • Table 140: Nevro Corporation Pipeline Products by Equipment Type
    • Table 141: Nevro Corporation Pipeline Products By Development Stage
    • Table 142: Nevro Corporation Pipeline Products By Therapy Area
    • Table 143: Wicab, Inc. Pipeline Products by Equipment Type
    • Table 144: Wicab, Inc. Pipeline Products By Development Stage
    • Table 145: Wicab, Inc. Pipeline Products By Therapy Area
    • Table 146: Wicab, Inc. Pipeline Products By Clinical Trials
    • Table 147: MICROTRANSPONDER, INC. Pipeline Products by Equipment Type
    • Table 148: MICROTRANSPONDER, INC. Pipeline Products By Development Stage
    • Table 149: MICROTRANSPONDER, INC. Pipeline Products By Therapy Area
    • Table 150: Neostim, Inc. Pipeline Products by Equipment Type
    • Table 151: Neostim, Inc. Pipeline Products By Development Stage
    • Table 152: Neostim, Inc. Pipeline Products By Therapy Area
    • Table 153: NeuroMetrix, Inc. Pipeline Products by Equipment Type
    • Table 154: NeuroMetrix, Inc. Pipeline Products By Development Stage
    • Table 155: NeuroMetrix, Inc. Pipeline Products By Therapy Area
    • Table 156: PhotoThera, Inc. Pipeline Products by Equipment Type
    • Table 157: PhotoThera, Inc. Pipeline Products By Development Stage
    • Table 158: PhotoThera, Inc. Pipeline Products By Therapy Area
    • Table 159: PhotoThera, Inc. Pipeline Products By Clinical Trials
    • Table 160: PhotoThera, Inc. Pipeline Products By News Summary
    • Table 161: BrainScope Company, Inc. Pipeline Products by Equipment Type
    • Table 162: BrainScope Company, Inc. Pipeline Products By Development Stage
    • Table 163: BrainScope Company, Inc. Pipeline Products By Therapy Area
    • Table 164: Vesta Acquires ExtruMed From Inverness Graham And Wedbush Capital
    • Table 165: Advanced Technology Acquisition To Acquire Bioness
    • Table 166: Intelect Medical Secures $11 Million In Financing
    • Table 167: Tang Capital Partners Terminates Acquisition Of Northstar Neuroscience
    • Table 168: Synergetics USA Enters Into An Agreement With Codman & Shurtleff
    • Table 169: Intelect Medical Enters Into An Agreement With Boston Scientific
    • Table 170: Concentric Medical Enters Into An Agreement With InTouch Health
    • Table 171: USD to Local Currency, Average Exchange Rate 2008
  • 1.2 List of Figures
    • Figure 1: United States, Healthcare Expenditure by Source, 2003
    • Figure 2: United States, Healthcare Infrastructure, Top Level View, 2007
    • Figure 3: Healthcare Expenses Segmentation by End User, 2003
    • Figure 4: Medical Equipment Approval Process in the United States, 2007
    • Figure 5: PMA Approval Process in the United States, 2007
    • Figure 6: The 510(k) Approval Process for Medical Devices in the United States, 2007
    • Figure 7: Reimbursement Structure in the United States, 2007
    • Figure 8: Distribution Structure of Medical Equipment in the United States, 2006
    • Figure 9: Neurology Devices Cross Country Comparison , Revenue ($ mn), 2000-2015
    • Figure 10: Neurology Devices, United States, Overall Revenue ($ mn), 2000-2015
    • Figure 11: Neurology Devices, United States, Cross-Category Analysis, 2000-2015
    • Figure 12: Neurology Devices, United States, Overall Revenue ($ mn), Historic, 2000-2008
    • Figure 13: Neurology Devices, United States, Overall Revenue ($ mn), Forecast, 2008-2015
    • Figure 14: Neurology Devices, United States, Company Share (%), 2007
    • Figure 15: CSF Management, United States, Revenue ($ mn) by Segment , Historic, 2000-2008
    • Figure 16: CSF Management, United States, Revenue ($ mn) by Segment , Forecast, 2008-2015
    • Figure 17: CSF Management, United States, Volume (Units), Historic, 2000-2008
    • Figure 18: CSF Management, United States, Volume (Units), Forecast, 2008-2015
    • Figure 19: CSF Management, United States, Company Share (%), 2007
    • Figure 20: Interventional Neurology, United States, Revenue ($ mn) by Segment , Historic, 2000-2008
    • Figure 21: Interventional Neurology, United States, Revenue ($ mn) by Segment , Forecast, 2008-2015
    • Figure 22: Embolic Systems, United States, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008
    • Figure 23: Embolic Systems, United States, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015
    • Figure 24: Navigational Systems, United States, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008
    • Figure 25: Navigational Systems, United States, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015
    • Figure 26: Interventional Neurology, United States, Volume (Units), Historic, 2000-2008
    • Figure 27: Interventional Neurology, United States, Volume (Units), Forecast, 2008-2015
    • Figure 28: Embolic Systems, United States, Volume (Units) by Sub-Segment, Historic, 2000-2008
    • Figure 29: Embolic Systems, United States, Volume (Units) by Sub-Segment, Forecast, 2008-2015
    • Figure 30: Navigational Systems, United States, Volume (Units) by Sub-Segment, Historic, 2000-2008
    • Figure 31: Navigational Systems, United States, Volume (Units) by Sub-Segment, Forecast, 2008-2015
    • Figure 32: Interventional Neurology, United States, Company Share (%), 2007
    • Figure 33: Neurostimulation Devices, United States, Revenue ($ mn) by Segment , Historic, 2000-2008
    • Figure 34: Neurostimulation Devices, United States, Revenue ($ mn) by Segment , Forecast, 2008-2015
    • Figure 35: Neurostimulation Devices, United States, Volume (Units), Historic, 2000-2008
    • Figure 36: Neurostimulation Devices, United States, Volume (Units), Forecast, 2008-2015
    • Figure 37: Neurostimulation Devices, United States, Company Share (%), 2007
    • Figure 38: Neurosurgical Products, United States, Revenue ($ mn) by Segment , Historic, 2000-2008
    • Figure 39: Neurosurgical Products, United States, Revenue ($ mn) by Segment , Forecast, 2008-2015
    • Figure 40: Neurosurgical Products, United States, Volume (Units), Historic, 2000-2008
    • Figure 41: Neurosurgical Products, United States, Volume (Units), Forecast, 2008-2015
    • Figure 42: Neurosurgical Products, United States, Company Share (%), 2007
    • Figure 43: Radiosurgery, United States, Company Share (%), 2007
    • Figure 44: Medtronic, Inc. Value Chain Analysis
    • Figure 45: Boston Scientific Corporation Value Chain Analysis
    • Figure 46: Elekta AB Value Chain Analysis
    • Figure 47: Olympus Medical Systems Corp. Value Chain Analysis
    • Figure 48: B. Braun Melsungen AG Value Chain Analysis
    • Figure 49: Accuray Incorporated Value Chain Analysis
    • Figure 50: Integra LifeSciences Holdings Corporation Value Chain Analysis
    • Figure 51: ev3 Inc. Value Chain Analysis
    • Figure 52: St. Jude Medical, Inc. Value Chain Analysis
    • Figure 53: VIASYS Healthcare Inc. Value Chain Analysis
    • Figure 54: Global Markets Direct Methodology

back to top

Delivery Details

PDF:Delivered by email usually within 12 to 24 UK business hours.

Ask a question about this product

Need help finding the right product?

Industry Events

#

Pharma & Healthcare

Customer Services

How To Buy
Formats & Delivery
Terms & Conditions
Account Options
Login/Register

call +44 (0) 20 7060 7474
or email us

Resources

Why Report Buyer?
Advertising/Affiliates
View Our Publishers
News
About Us
Meet Us
Jobs
Contact Us
Categories and Subcategories

Post it

Del.icio.us
StumbleUpon
Reddit

logo: AddThis